Monsanto (MON) was downgraded to neutral at Citigroup. $95 price target. The company lacks near-term catalysts, Citigroup said.
Team Health (TMH) was downgraded to neutral from overweight at JPMorgan. The valuation isn't as attractive, based on a $47 price target.
Tesla Motors (TSLA - Get Report) was upgraded to neutral from outperform at Robert Baird. $300 price target. Production appears to be accelerating, which should drive margin expansion, Robert Baird said.